MM&M

Drugmakers target severe asthma patients with biologics, but payers raise pricing issue

AstraZeneca is developing an investigative anti-eosinophil monoclonal antibody benralizumab that can be administered subcutaneously in an at-home setting. Drug development in the severe asthma space ...
Yahoo Finance

Asthma Market, Pipeline, and Competition Analysis Report, 2024: Features Insights on 90+ Companies and 100+ Pipeline Drugs, Including Dexpramipexole, TQC2731, and SHR-1703

Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Asthma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights about ...
Yahoo Finance

Severe Asthma Therapeutics Pipeline Market Report 2024: Comprehensive Insights about 50+ Companies and 55+ Pipeline Drugs

Dublin, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The "Severe Asthma - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering. This "Severe Asthma - Pipeline Insight, 2024" ...
Business Insider

Allergy Program Announces First CERTIFIED asthma & allergy friendly® Commercial Vacuum CleanerSanitaire® EON™ Offers Solution for Offices, Hospitals and Schools

Washington, DC, April 12, 2018 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL) announced that Sanitaire® EON™ ALLERGEN Upright Vacuum ...
clinicaladvisor.com

GINA 2024 Asthma Update: Revised Recommendations on Treatment, Goals, Remission

Credit: Getty Images The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more. The Global Initiative for ...